291 related articles for article (PubMed ID: 23012630)
1. Herpesviruses placating the unwilling host: manipulation of the MHC class II antigen presentation pathway.
Zuo J; Rowe M
Viruses; 2012 Aug; 4(8):1335-53. PubMed ID: 23012630
[TBL] [Abstract][Full Text] [Related]
2. Herpesviruses and immunity: the art of evasion.
Griffin BD; Verweij MC; Wiertz EJ
Vet Microbiol; 2010 Jun; 143(1):89-100. PubMed ID: 20303681
[TBL] [Abstract][Full Text] [Related]
3. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.
Thakker S; Purushothaman P; Gupta N; Challa S; Cai Q; Verma SC
J Virol; 2015 May; 89(10):5536-56. PubMed ID: 25740990
[TBL] [Abstract][Full Text] [Related]
4. Kaposi's sarcoma-associated herpesvirus-encoded viral IRF3 modulates major histocompatibility complex class II (MHC-II) antigen presentation through MHC-II transactivator-dependent and -independent mechanisms: implications for oncogenesis.
Zuo J; Hislop AD; Leung CS; Sabbah S; Rowe M
J Virol; 2013 May; 87(10):5340-50. PubMed ID: 23449805
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the MHC class II antigen presentation pathway by human cytomegalovirus.
Johnson DC; Hegde NR
Curr Top Microbiol Immunol; 2002; 269():101-15. PubMed ID: 12224504
[TBL] [Abstract][Full Text] [Related]
6. Exploiting human herpesvirus immune evasion for therapeutic gain: potential and pitfalls.
Horst D; Ressing ME; Wiertz EJ
Immunol Cell Biol; 2011 Mar; 89(3):359-66. PubMed ID: 21301483
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of interference with the MHC class I-restricted pathway of antigen presentation by herpesviruses.
Hill AB
Immunol Cell Biol; 1996 Dec; 74(6):523-6. PubMed ID: 8989590
[TBL] [Abstract][Full Text] [Related]
8. Herpes simplex virus type 1 targets the MHC class II processing pathway for immune evasion.
Neumann J; Eis-Hübinger AM; Koch N
J Immunol; 2003 Sep; 171(6):3075-83. PubMed ID: 12960333
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: a novel mechanism for evading major histocompatibility complex class II antigen presentation.
Hegde NR; Tomazin RA; Wisner TW; Dunn C; Boname JM; Lewinsohn DM; Johnson DC
J Virol; 2002 Nov; 76(21):10929-41. PubMed ID: 12368336
[TBL] [Abstract][Full Text] [Related]
10. The MHC class I antigen presentation pathway: strategies for viral immune evasion.
Hewitt EW
Immunology; 2003 Oct; 110(2):163-9. PubMed ID: 14511229
[TBL] [Abstract][Full Text] [Related]
11. Immune evasion during varicella zoster virus infection of keratinocytes.
Black AP; Jones L; Malavige GN; Ogg GS
Clin Exp Dermatol; 2009 Dec; 34(8):e941-4. PubMed ID: 19549245
[TBL] [Abstract][Full Text] [Related]
12. Equine herpesvirus type 4 UL56 and UL49.5 proteins downregulate cell surface major histocompatibility complex class I expression independently of each other.
Said A; Azab W; Damiani A; Osterrieder N
J Virol; 2012 Aug; 86(15):8059-71. PubMed ID: 22623773
[TBL] [Abstract][Full Text] [Related]
13. The herpesvirus stealth program.
Huang T; Osterrieder N
Oncotarget; 2015 Sep; 6(26):21761-2. PubMed ID: 26335280
[No Abstract] [Full Text] [Related]
14. Human Cytomegalovirus Decreases Major Histocompatibility Complex Class II by Regulating Class II Transactivator Transcript Levels in a Myeloid Cell Line.
Sandhu PK; Buchkovich NJ
J Virol; 2020 Mar; 94(7):. PubMed ID: 31915281
[TBL] [Abstract][Full Text] [Related]
15. MHC class II antigen presentation pathway in murine tumours: tumour evasion from immunosurveillance?
Walter W; Lingnau K; Schmitt E; Loos M; Maeurer MJ
Br J Cancer; 2000 Nov; 83(9):1192-201. PubMed ID: 11027433
[TBL] [Abstract][Full Text] [Related]
16. Major histocompatibility complex class II+ invariant chain negative breast cancer cells present unique peptides that activate tumor-specific T cells from breast cancer patients.
Chornoguz O; Gapeev A; O'Neill MC; Ostrand-Rosenberg S
Mol Cell Proteomics; 2012 Nov; 11(11):1457-67. PubMed ID: 22942358
[TBL] [Abstract][Full Text] [Related]
17. Immune escape of γ-herpesviruses from adaptive immunity.
Hu Z; Usherwood EJ
Rev Med Virol; 2014 Nov; 24(6):365-78. PubMed ID: 24733560
[TBL] [Abstract][Full Text] [Related]
18. Parasite Manipulation of the Invariant Chain and the Peptide Editor H2-DM Affects Major Histocompatibility Complex Class II Antigen Presentation during Toxoplasma gondii Infection.
Leroux LP; Nishi M; El-Hage S; Fox BA; Bzik DJ; Dzierszinski FS
Infect Immun; 2015 Oct; 83(10):3865-80. PubMed ID: 26195549
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus evades CD4+ T cell responses in lytic cycle through BZLF1-mediated downregulation of CD74 and the cooperation of vBcl-2.
Zuo J; Thomas WA; Haigh TA; Fitzsimmons L; Long HM; Hislop AD; Taylor GS; Rowe M
PLoS Pathog; 2011 Dec; 7(12):e1002455. PubMed ID: 22216005
[TBL] [Abstract][Full Text] [Related]
20. A CD4
Lawler C; Stevenson PG
J Virol; 2020 Jan; 94(3):. PubMed ID: 31694958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
